DEA schedule
Is bupropion a controlled substance?
Federal schedule for bupropion from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Bupropion is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and bupropion is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted bupropion?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 349 prescription listings from 81 labelers, none with a DEA schedule |
| DEA controlled substances list | bupropion is not on the list |
Bupropion NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0187-5810 | Aplenzin | tablet, extended release | 174 mg/1 | Bausch Health US, LLC | None |
| 0187-5811 | Aplenzin | tablet, extended release | 348 mg/1 | Bausch Health US, LLC | None |
| 0187-5812 | Aplenzin | tablet, extended release | 522 mg/1 | Bausch Health US, LLC | None |
| 70756-830 | BUPROPION HCl ER (XL) | tablet, extended release | 450 mg/1 | Lifestar Pharma LLC | None |
| 24979-247 | Forfivo XL | tablet, film coated, extended release | 450 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 0187-0730 | WELLBUTRIN XL | tablet, extended release | 150 mg/1 | Bausch Health US LLC | None |
| 0187-0731 | WELLBUTRIN XL | tablet, extended release | 300 mg/1 | Bausch Health US LLC | None |
| 0173-0947 | WELLBUTRIN SR | tablet, film coated | 100 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0135 | WELLBUTRIN SR | tablet, film coated | 150 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0722 | WELLBUTRIN SR | tablet, film coated | 200 mg/1 | GlaxoSmithKline LLC | None |
| 65841-836 | bupropion | tablet, extended release | 150 mg/1 | Zydus Lifesciences Limited | None |
| 68382-353 | bupropion | tablet, extended release | 150 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 71205-565 | bupropion | tablet, extended release | 150 mg/1 | Proficient Rx LP | None |
| 71335-0801 | bupropion | tablet, extended release | 200 mg/1 | Bryant Ranch Prepack | None |
| 63187-521 | bupropion | tablet, extended release | 300 mg/1 | Proficient Rx LP | None |
| 65841-780 | bupropion | tablet, extended release | 300 mg/1 | Zydus Lifesciences Limited | None |
| 68382-354 | bupropion | tablet, extended release | 300 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 51655-357 | bupropion | tablet, film coated, extended release | 150 mg/1 | Northwind Health Company, LLC | None |
| 72189-457 | Bupropion HCL | tablet, film coated | 100 mg/1 | Direct_Rx | None |
| 61919-558 | Bupropion HCL ER (XL) | tablet, extended release | 150 mg/1 | Direct_Rx | None |
| 72189-539 | Bupropion HCL ER (XL) | tablet, extended release | 300 mg/1 | Direct_RX | None |
| 72189-676 | Bupropion HCL ER(SR) | tablet, extended release | 100 mg/1 | DriectRx | None |
| 68682-580 | Bupropion Hydrobromide | tablet, extended release | 174 mg/1 | Oceanside Pharmaceuticals | None |
| 68682-581 | Bupropion Hydrobromide | tablet, extended release | 348 mg/1 | Oceanside Pharmaceuticals | None |
| 68682-582 | Bupropion Hydrobromide | tablet, extended release | 522 mg/1 | Oceanside Pharmaceuticals | None |
| 0904-7530 | Bupropion Hydrochloride | tablet | 100 mg/1 | MAJOR PHARMACEUTICALS | None |
| 23155-192 | bupropion Hydrochloride | tablet | 100 mg/1 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 43063-994 | bupropion Hydrochloride | tablet | 100 mg/1 | PD-Rx Pharmaceuticals, Inc. | None |
| 51655-390 | bupropion Hydrochloride | tablet | 100 mg/1 | Northwind Health Company, LLC | None |
| 62135-724 | Bupropion Hydrochloride | tablet | 100 mg/1 | Chartwell RX, LLC | None |
| 67046-1562 | Bupropion Hydrochloride | tablet | 100 mg/1 | Coupler LLC | None |
| 67046-1672 | bupropion Hydrochloride | tablet | 100 mg/1 | Coupler LLC | None |
| 69097-918 | bupropion Hydrochloride | tablet | 100 mg/1 | CIPLA USA INC., | None |
| 71335-0877 | bupropion Hydrochloride | tablet | 100 mg/1 | Bryant Ranch Prepack | None |
| 71335-2690 | bupropion Hydrochloride | tablet | 100 mg/1 | Bryant Ranch Prepack | None |
| 71335-2875 | bupropion Hydrochloride | tablet | 100 mg/1 | Bryant Ranch Prepack | None |
| 72162-2401 | bupropion Hydrochloride | tablet | 100 mg/1 | Bryant Ranch Prepack | None |
| 72789-544 | bupropion Hydrochloride | tablet | 100 mg/1 | PD-Rx Pharmaceuticals, Inc. | None |
| 68001-613 | Bupropion hydrochloride | tablet | 150 mg/1 | BluePoint Laboratories | None |
| 70518-4448 | Bupropion hydrochloride | tablet | 150 mg/1 | REMEDYREPACK INC. | None |
Showing 40 of 349 listings.
Questions
Is bupropion a controlled substance?
No. Bupropion is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and bupropion is not on the DEA controlled substances list.
Is bupropion a narcotic?
No. Bupropion is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Aminoketone.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Bupropion
- What is Bupropion used for?FDA label uses
- Generic for AplenzinFDA Orange Book
- Generic for Forfivo XLFDA Orange Book
- Generic for Wellbutrin SRFDA Orange Book
- Generic for Wellbutrin XLFDA Orange Book
- Generic for ZybanFDA Orange Book
- Generic for WellbutrinFDA Orange Book
- Aminoketones listFDA drug class
- NDC 0173-0135Bupropion NDC record
- NDC 0173-0722Bupropion NDC record
- NDC 0173-0947Bupropion NDC record